Eledon Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2017 to 2023.
  • Eledon Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $9.78M.
  • Eledon Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$45.3M.
  • Eledon Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $11M.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$45.3M Jan 1, 2023 Dec 31, 2023 10-K/A 2024-08-19
2020 $11M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2017 $23.3M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.